Clinical trial finds novel therapy markedly reduces lipoprotein(a) levels in people with cardiovascular disease
Lipoprotein(a) is a special type of bad cholesterol that is believed to contribute to heart disease, but there are no approved pharmacological therapies to decrease its concentration in the bloodstream. Olpasiran is an investigational ...
Nov 7, 2022
1
31